Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-13

FDA Approved: GLIMEPIRIDE — Supplemental Application (Florida Pharmaceutical Products, LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic version of glimepiride manufactured by Florida Pharmaceutical Products, LLC. No new indications or lab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)